Avid Bioservices, Inc. PPHM
No live quote for PPHM yet.
Analyst view
Consensus: buy
Buy
Price target (mean) 10.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.14 | -0.14 – -0.14 | -0.28 | +50.0% | 8.90M | -17.2% | 1 |
| Next quarter | -0.10 | -0.10 – -0.10 | -0.16 | +37.5% | 6.70M | -62.6% | 1 |
| Current year | -0.57 | -0.57 – -0.57 | -0.88 | +35.2% | 55.50M | -3.7% | 1 |
| Next year | 0.00 | 0.00 – 0.00 | -0.57 | 0.0% | 65.97M | +18.9% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 25, 2016 | Roth Capital | Downgrade | — | Neutral |
| Feb 25, 2016 | Roth Capital | Downgrade | — | Neutral |
| Mar 4, 2013 | PiperJaffray | Initiated | — | Overweight |
| Jan 6, 2013 | Roth Capital | Upgrade | — | Buy |
| Sep 23, 2012 | Roth Capital | Downgrade | — | Neutral |
| Apr 12, 2012 | LifeTech Capital | Downgrade | — | Neutral |